GSK plc

Open: 41.57 Close: 41.39 Change: -0.18

Our AI found some flaws in GSK plc.

This document will help you to evaluate GSK plc without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about GSK plc are: GSK, PLC, stock, market, month, GlaxoSmithKline, price, …

Concept Map

Semantic Network

Stock Summary

GSK plc engages in the research, development and manufacture of vaccines and specialty medicines. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company was formerly known as Gl.

Today's Summary

GSK PLC shares inched up 0.95% to £16.42 on Tuesday, on what proved to be an all-around dismal trading session for the stock market. GSK beat market estimates for fourth-quarter profit and sales on Wednesday. The company is set to release earnings on 2024-04-30.

Today's News

GSK PLC shares inched up 0.95% to £16.42 on Tuesday, on what proved to be an all-around dismal trading session for the stock market. GSK plc has risen 2.42% over the past month, closing at $39.88 on January 16. The company is set to release earnings on 2024-04-30. GSK beat market estimates for fourth-quarter profit and sales on Wednesday, underpinned by a strong launch of its respiratory syncytial virus (RSV) vaccine Arexvy and steady demand for its shingles vaccine. GSK will sell a 3.2% stake in spin-off consumer healthcare business Haleon. GSK PLC shares advanced 1.19% to £16.73 on what proved to be an all-around dismal trading session for the stock market. FTSE 100 Index UKX, -0.81% falling 0.68% to 7,628.75. GSK shares hit a new 52-week high, surpassing its previous peak of £16. GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. GSK PLC ADR U.S.: NYSE Add to Watchlist 0.39 +0.32 (+0.78%) Share Price as of February 13. Glaxo (GSK) beats earnings as well as revenues estimates in the fourth quarter of 2021. Gilead (GILD) misses on earnings but beats on sales in fourth quarter. GlaxoSmithKline (GSK) closed at $45.10, marking a +0.49% move from the previous day. J&J (JNJ) to Set the Stage for Pharma Sector Q4 Earnings by Zacks Equity Research. GSK plc has risen 4.51% over the past month, closing at $39.88 on January 15. GSK has an average analyst recommendation of Sell. GSK provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. GSK PLC stock price is 41.07 USD today. The current trend is moderately bullish and GSK is experiencing slight selling pressure. The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction. GlaxoSmithKline PLC is undervalued by 32% compared to the current market price of 41.39 USD. Wall Street analysts forecast GSK stock price to rise over the next 12 months. GSK projects Continued Growth and Profit Increases 2023-Q4 Earnings Call. GSK has positive three-year average ROIC (Return on Invested Capital) for the past 12 months. Revenue has been growing by 8% per year for the last 3 years. Long-term assets (59B GBP) exceed its long-term liabilties (46B GBp) Short-term Solvency GSK s short-term. assets (21B GBbasic MGTP£ feudal pressures ARM Berk Podcastム 426stab undetaire unlock Citi upgraded its rating for GSK, previously called GlaxoSmithKline, to Buy from Hold and raised the price target for the stock to £21 from £17. Citi analyst Andrew Baum said that aside from the underappreciated top-line potential of Blenrep, there are many more reasons behind his bullish stance. GSK Raised to Buy at Citi After Cancer Drug Data 1 Report Moomoo AI: GSK optimistic long-term outlook driven by the expected launch of at least 12 major products from 2025.

Stock Profile

"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom."

Keywords

Are looking for the most relevant information about GSK plc? Investor spend a lot of time searching for information to make investment decisions in GSK plc. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about GSK plc are: GSK, PLC, stock, market, month, GlaxoSmithKline, price, and the most common words in the summary are: gsk, stock, market, price, plc, company, news, . One of the sentences in the summary was: GSK PLC shares inched up 0.95% to £16.42 on Tuesday, on what proved to be an all-around dismal trading session for the stock market. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #gsk #stock #market #price #plc #company #news.